Saroja Pharma Industries India shareholders and shareholding pattern
NSE: SAROJAChemicals & Petrochemicals
Saroja Pharma Industries India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2023 · Issue price ₹84
Last close ₹38.80down ₹2.00 (4.90%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹40.80.
28 Oct: open ₹38.80, high ₹38.80, low ₹38.80
52-week range of traded prices to 28 Oct 2026
₹28.00Low, 30 Mar 2026₹43.65High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹16 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.83
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,600100.0% delivered
Saroja Pharma Industries India's shareholding pattern for Sep 2026, filed on 17 Oct 2026, with every filing from Sep 2023: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Saroja Pharma Industries India, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters73.02%
- Individuals and others26.98%
Shareholding pattern, per cent
- Promoters
- Individuals and others
| Per cent | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | |
| Indian promoters | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 26.99% | 26.98% | 26.98% | 26.98% | 26.98% | 26.98% | 26.98% |
| Shares in issue | 40,20,486 | 40,20,486 | 40,20,486 | 40,20,486 | 40,20,486 | 40,20,486 | 40,20,486 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 29,35,686 | 29,35,686 | 8,04,800 | 8,04,800 | 8,04,800 | 8,04,800 | – |
| Promoters' shares locked in | 29,35,686 | 29,35,686 | 8,04,800 | 8,04,800 | 8,04,800 | 8,04,800 | – |
A dash is a line the filing did not state.
Saroja Pharma Industries India promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is BIJU GOPINATHAN NAIR, 72.05%.
| Holder | ||
|---|---|---|
| BIJU GOPINATHAN NAIRIndividuals and Hindu undivided families | 72.05% | 28,96,672 |
| MANISH DASHARATH KAMBLEIndividuals and Hindu undivided families | 0.97% | 39,000 |
| SAROJA NAIRIndividuals and Hindu undivided families | 0.00% | 2 |
| PULINATTU DAMODARAN NANDAKUMARIndividuals and Hindu undivided families | 0.00% | 2 |
| ADITRI BIJU NAIRIndividuals and Hindu undivided families | 0.00% | 2 |
| SONAL SIDDARTH DIWADKARIndividuals and Hindu undivided families | 0.00% | 2 |
| BINDU RAMACHANDRAN KURUPIndividuals and Hindu undivided families | 0.00% | 2 |
| SUSHAMA DASHARATH KAMBLEIndividuals and Hindu undivided families | 0.00% | 2 |
| RETHI KRISHNAN NAIRIndividuals and Hindu undivided families | 0.00% | 2 |
No promoter shares are reported as pledged.
Largest public holders of Saroja Pharma Industries India, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| SWASTIKA INVESTMART LTDCompanies | 1.55% | 1.39% | – | 1.91% | 1.87% | 1.99% | 1.39% |
| KAMLESH NATWARLAL SHAHResident individuals, over ₹2 lakh at face value | – | 1.31% | 1.31% | 1.31% | 1.31% | 1.31% | 1.31% |
| PRANAY DATTATREY RAUTResident individuals, over ₹2 lakh at face value | – | – | 1.19% | 1.43% | – | – | – |
| VARDAAN NAGPALResident individuals, over ₹2 lakh at face value | – | – | 1.03% | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Mar 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: SWASTIKA INVESTMART LTD 1.39%, −0.60 pts